# A Randomised Controlled Trial to Compare Two Supraglottic Airway Devices (Ambu AuraGain vs Air Q-3) in Terms of Performance Characteristics.

> **NCT06914453** · NA · COMPLETED · sponsor: **University of Malaya** · enrollment: 90 (actual)

## Conditions studied

- Oropharyngeal Leak Pressure
- Supraglottic Airway
- Elective Surgery
- General Anaesthesia

## Interventions

- **DEVICE:** Air Q-3 Supraglottic Airway Device
- **DEVICE:** Ambu AuraGain Supraglottic Airway Device

## Key facts

- **NCT ID:** NCT06914453
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-26
- **Primary completion:** 2025-01-24
- **Final completion:** 2025-01-24
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914453, "A Randomised Controlled Trial to Compare Two Supraglottic Airway Devices (Ambu AuraGain vs Air Q-3) in Terms of Performance Characteristics.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06914453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*